| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Linda L Demer | Q42562196 |
| P2093 | author name string | Yin Tintut | |
| P2860 | cites work | Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis | Q24301047 |
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging | Q24311723 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality | Q24623768 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification | Q24684936 | ||
| Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
| Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells | Q28141829 | ||
| Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival | Q28142897 | ||
| Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues | Q28208566 | ||
| Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation | Q28240596 | ||
| Vascular calcification: pathobiology of a multifaceted disease | Q28282418 | ||
| RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships | Q30430568 | ||
| A novel molecular mechanism modulating osteoclast differentiation and function | Q30643494 | ||
| ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells | Q33280147 | ||
| Hyperlipidemia impairs osteoanabolic effects of PTH. | Q33337922 | ||
| Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women | Q33510427 | ||
| Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss | Q33585814 | ||
| Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids | Q33784464 | ||
| Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress | Q79375604 | ||
| Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin | Q79544434 | ||
| Regulation of bone lysis in inflammatory diseases | Q79808629 | ||
| A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin | Q79839208 | ||
| Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice | Q79903873 | ||
| Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis | Q80413873 | ||
| Role of osteoprotegerin in arterial calcification: development of new animal model | Q80576674 | ||
| Calcifications in the abdominal aorta predict fractures in men: MINOS study | Q81345932 | ||
| Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function | Q81419745 | ||
| A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks | Q81514904 | ||
| Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening | Q81607497 | ||
| Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment | Q84211353 | ||
| The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 | ||
| Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells | Q33987854 | ||
| Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease | Q34019132 | ||
| Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells | Q34022425 | ||
| Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation | Q34065287 | ||
| TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. | Q34145009 | ||
| Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration | Q34220388 | ||
| Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts. | Q34402832 | ||
| Vascular calcification and bone disease: the calcification paradox | Q34611565 | ||
| Immune function of the decoy receptor osteoprotegerin. | Q35033065 | ||
| Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women | Q35093777 | ||
| Bone density and hyperlipidemia: the T-lymphocyte connection | Q35229853 | ||
| Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. | Q35754620 | ||
| Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification | Q35816570 | ||
| Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans | Q35831451 | ||
| Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids | Q35853986 | ||
| Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture | Q35862512 | ||
| Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis | Q36368706 | ||
| Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish | Q36653061 | ||
| Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. | Q36678487 | ||
| Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients | Q37078140 | ||
| Aortic sclerosis, aortic stenosis and lipid-lowering therapy | Q37104873 | ||
| Apo A-1 mimetic peptides as atheroprotective agents in murine models | Q37108299 | ||
| Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. | Q37188485 | ||
| The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair | Q37263382 | ||
| Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton | Q37448064 | ||
| Lipid lowering and aortic valve disease | Q37576121 | ||
| Does calcium supplementation increase cardiovascular risk? | Q37698674 | ||
| Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity | Q37830940 | ||
| Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone | Q39116021 | ||
| Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis | Q39124107 | ||
| High-density lipoprotein regulates calcification of vascular cells. | Q39265314 | ||
| Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling | Q39804721 | ||
| Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells | Q40017911 | ||
| Do statins slow the progression of aortic valve stenosis? | Q40102551 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| Bone morphogenetic protein expression in human atherosclerotic lesions. | Q40304303 | ||
| Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
| Expression and function of TNF-family proteins and receptors in human osteoblasts. | Q40616037 | ||
| Multilineage potential of cells from the artery wall. | Q40622386 | ||
| 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway | Q40752751 | ||
| Stimulation of bone formation in vitro and in rodents by statins | Q40914337 | ||
| The missing bone | Q41496768 | ||
| Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors | Q41608135 | ||
| Lowering plasma cholesterol levels halts progression of aortic valve disease in mice | Q41946374 | ||
| Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification | Q42994159 | ||
| Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats | Q43044963 | ||
| Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption | Q43604722 | ||
| Oxidative stress modulates osteoblastic differentiation of vascular and bone cells | Q43702897 | ||
| Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. | Q43764592 | ||
| TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells | Q43821708 | ||
| PTH differentially regulates expression of RANKL and OPG. | Q43832667 | ||
| Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease | Q43865169 | ||
| Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone | Q43993807 | ||
| Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes | Q44159309 | ||
| Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice | Q44429147 | ||
| The predictive power of low-density lipoprotein cholesterol for coronary calcification | Q44575036 | ||
| RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway | Q44590687 | ||
| Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption | Q44590734 | ||
| Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice | Q44592811 | ||
| Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. | Q44683819 | ||
| Relationship between lipids and bone mass in 2 cohorts of healthy women and men. | Q44688641 | ||
| Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo | Q44690058 | ||
| Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification | Q45200610 | ||
| N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. | Q45935973 | ||
| Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. | Q45946808 | ||
| RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway | Q46072800 | ||
| Monocyte/macrophage regulation of vascular calcification in vitro | Q46083654 | ||
| Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women | Q46130374 | ||
| Pericytes derived from the retinal microvasculature undergo calcification in vitro | Q46273892 | ||
| Regulation of RANKL-induced osteoclastic differentiation by vascular cells | Q46283747 | ||
| Atherogenic high-fat diet reduces bone mineralization in mice | Q46289468 | ||
| Lipid hypothesis of cardiovascular calcification | Q46292905 | ||
| Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure. | Q46296691 | ||
| Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium. | Q46408797 | ||
| Rationale for the role of osteoclast-like cells in arterial calcification | Q46559477 | ||
| Genetic determination of cartilaginous metaplasia in mouse aorta. | Q46608623 | ||
| Oxidized low-density lipoprotein acts synergistically with beta-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells | Q46608634 | ||
| Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals | Q46614616 | ||
| A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response | Q46743257 | ||
| Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification | Q46830525 | ||
| Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo | Q46881126 | ||
| Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation | Q46937168 | ||
| RANKL links arterial calcification with osteolysis | Q47857745 | ||
| Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro | Q48459182 | ||
| Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice | Q48900425 | ||
| Chondrogenic and adipogenic potential of microvascular pericytes. | Q50784818 | ||
| Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. | Q51838900 | ||
| Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. | Q52118613 | ||
| Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). | Q53477615 | ||
| Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. | Q54074255 | ||
| Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | Q54137269 | ||
| Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption | Q58085856 | ||
| In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population | Q59080212 | ||
| Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry | Q59307017 | ||
| Time course of oxysterol formation during in vitro oxidation of low density lipoprotein | Q59307019 | ||
| Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction | Q59587158 | ||
| Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries | Q62056241 | ||
| Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells | Q64380010 | ||
| Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions | Q70718490 | ||
| Matrix vesicles in atherosclerotic calcification | Q71671852 | ||
| Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification | Q73075489 | ||
| Increased osteoprotegerin serum levels in men with coronary artery disease | Q73106368 | ||
| Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men | Q73167301 | ||
| Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway | Q73209080 | ||
| Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency | Q73418675 | ||
| Bone formation and inflammation in cardiac valves | Q73635711 | ||
| Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis | Q73684776 | ||
| Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study | Q74152546 | ||
| A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function | Q74259336 | ||
| PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways | Q74308465 | ||
| Osteoprotegerin: a link between osteoporosis and arterial calcification? | Q74348478 | ||
| Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease | Q74711101 | ||
| Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification | Q75301236 | ||
| Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques | Q77350558 | ||
| Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice | Q77520948 | ||
| P433 | issue | 12 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1482-1493 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification | |
| P478 | volume | 108 |
| Q27677250 | 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε |
| Q53001553 | Alteration of inflammatory response by shock wave therapy leads to reduced calcification of decellularized aortic xenografts in mice†. |
| Q36738086 | Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cells |
| Q33568822 | Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase |
| Q36177303 | Arterial calcification and bone physiology: role of the bone-vascular axis |
| Q36592995 | Blunted temporal activity of microvascular perfusion heterogeneity in metabolic syndrome: a new attractor for peripheral vascular disease? |
| Q36648170 | Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links |
| Q42872632 | Chronic kidney disease: the "perfect storm" of cardiometabolic risk illuminates genetic diathesis in cardiovascular disease |
| Q54293068 | Correlation between osteocalcin-positive endothelial progenitor cells and spotty calcification in patients with coronary artery disease. |
| Q26994661 | Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models |
| Q36930213 | Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis |
| Q38881440 | Losartan Inhibits Nuclear Factor-κB Activation Induced by Small, Dense LDL Cholesterol Particles in Human Umbilical Vein Endothelial Cells |
| Q26821993 | Mechanisms of arterial calcifications and consequences for cardiovascular function |
| Q28394742 | Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling |
| Q37347202 | Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats |
| Q38167348 | Positron emission tomography of the vulnerable atherosclerotic plaque in man--a contemporary review |
| Q40345587 | ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation. |
| Q34620107 | ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation |
| Q28115789 | Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-γ in CD36 Protein Expression and Foam Cell Formation |
| Q47133991 | Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis. |
| Q36769105 | The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury |
| Q47703344 | The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis |
| Q47237041 | The protective effect of PFTα on alcohol-induced osteonecrosis of the femoral head |
| Q54324442 | Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts. |
| Q50205468 | ox-LDL increases microRNA-29a transcription through upregulating YY1 and STAT1 in macrophages |
Search more.